2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

Catalog No. :
ACPKZM645
CAS No. :
1246765-29-6
Molecular Formula :
C14H20BNO3
Molecular Weight :
261.13

IUPAC Name:2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$126.00Login to see priceInquiryInquiry
250mg98%$199.00Login to see priceInquiryInquiry
1g98%$382.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
IUPAC Name2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
MDL No.MFCD18383506
Molecular FormulaC14H20BNO3
Molecular Weight261.13
SMILESO=C(N)C1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1C
InChI KeyMZJPXQGWYNZKJS-UHFFFAOYSA-N
Synonym2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;Benzamide, 2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1246765-29-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPKZM645 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACVXJY241 route compound structure diagram
    ACVXJY241868776-08-3 In Stock
  4. Then
  5. ACPKZM645 route product structure diagram
    ACPKZM6451246765-29-6
Inquiry

2. ACPKZM645 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVXJY241 route compound structure diagram
    ACVXJY241868776-08-3 In Stock
  2. Then
  3. ACPKZM645 route product structure diagram
    ACPKZM6451246765-29-6
Inquiry

Comments (0)